4-(2-(2,7-dibromo-9H-carbazol-9-yl)ethyl)morpholine | 1616114-31-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-(2-(2,7-dibromo-9H-carbazol-9-yl)ethyl)morpholine
• 英文别名: 4-(2-(2,7-dibromo-9H-carbazole-9-yl)ethyl)morpholine；4-[2-(2,7-Dibromocarbazol-9-yl)ethyl]morpholine；4-[2-(2,7-dibromocarbazol-9-yl)ethyl]morpholine
• CAS: 1616114-31-8
• 化学式: C₁₈H₁₈Br₂N₂O
• 分子量: 438.162
• InChiKey: RQLPLVNEYKVDQJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  23
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  17.4
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• [EN] MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS<br/>[FR] DÉRIVÉS DE MANNOSE POUR LE TRAITEMENT D'INFECTIONS BACTÉRIENNES
  申请人：VERTEX PHARMA

  公开号：WO2014100158A1

  公开（公告）日：2014-06-26

  The present invention relates to compounds useful for the treatment or prevention of bacteria infections. These compounds have formula (I). The invention also provides pharmaceutically acceptable compositions containing the compounds and methods of using the compositions in the treatment of bacteria infections. Finally, the invention provides processes for making compounds of the invention.

  本发明涉及用于治疗或预防细菌感染的化合物。这些化合物具有化学式（I）。该发明还提供含有这些化合物的药学上可接受的组合物，以及使用这些组合物治疗细菌感染的方法。最后，该发明提供了制备本发明化合物的方法。
• CARBAZOLE COMPOUND HAVING ANTI-VIRUS ACTIVITY
  申请人：KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY

  公开号：US20180057527A1

  公开（公告）日：2018-03-01

  The present invention relates to a carbazole compound having anti-virus activity, and more particularly, to a novel compound selected from the group of consisting of a carbazole compound which shows excellent anti-proliferative efficacy against hepatitis C virus (HCV), a pharmaceutically acceptable salt thereof, a hydrate thereof, and an isomer thereof; an anti-virus pharmaceutical composition including the novel compound as an active ingredient; a pharmaceutical composition for preventing or treating liver diseases caused by hepatitis C virus; and a method of preparing the novel compound.

  本发明涉及一种具有抗病毒活性的咔唑化合物，更具体地说，涉及一种从咔唑化合物组中选择的新化合物，该化合物对丙型肝炎病毒（HCV）表现出优异的抗增殖功效，其药用盐、水合物和异构体；包括该新化合物作为活性成分的抗病毒药物组合物；用于预防或治疗由丙型肝炎病毒引起的肝病的药物组合物；以及制备该新化合物的方法。
• MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS
  申请人：Vertex Pharmaceuticals Incorporated

  公开号：US20140243283A1

  公开（公告）日：2014-08-28

  The present invention relates to compounds useful for the treatment or prevention of bacteria infections. These compounds have formula I: The invention also provides pharmaceutically acceptable compositions containing the compounds and methods of using the compositions in the treatment of bacteria infections. Finally, the invention provides processes for making compounds of the invention.

  本发明涉及用于治疗或预防细菌感染的化合物。这些化合物的化学式为I：本发明还提供包含该化合物的药学上可接受的组合物，并提供使用该组合物治疗细菌感染的方法。最后，本发明提供了制备该化合物的方法。
• Mannose Derivatives for Treating Bacterial Infections
  申请人：Vertex Pharmaceuticals Incorporated

  公开号：US20160235775A1

  公开（公告）日：2016-08-18

  The present invention relates to compounds useful for the treatment or prevention of bacteria infections. These compounds have formula I: The invention also provides pharmaceutically acceptable compositions containing the compounds and methods of using the compositions in the treatment of bacteria infections. Finally, the invention provides processes for making compounds of the invention.

  本发明涉及用于治疗或预防细菌感染的化合物。这些化合物的化学式为I：本发明还提供了含有这些化合物的药学上可接受的组合物以及使用这些组合物治疗细菌感染的方法。最后，本发明还提供了制备本发明化合物的方法。
• Carbazole compound having anti-virus activity
  申请人：KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY

  公开号：US10421779B2

  公开（公告）日：2019-09-24

  The present invention relates to a carbazole compound having anti-virus activity, and more particularly, to a novel compound selected from the group of consisting of a carbazole compound which shows excellent anti-proliferative efficacy against hepatitis C virus (HCV), a pharmaceutically acceptable salt thereof, a hydrate thereof, and an isomer thereof; an anti-virus pharmaceutical composition including the novel compound as an active ingredient; a pharmaceutical composition for preventing or treating liver diseases caused by hepatitis C virus; and a method of preparing the novel compound.

  本发明涉及一种具有抗病毒活性的咔唑化合物，更具体地说，涉及一种选自以下组成的组别的新型化合物：一种对丙型肝炎病毒（HCV）具有优异抗增殖功效的咔唑化合物、其药学上可接受的盐、其水合物和其异构体；一种包括该新型化合物作为活性成分的抗病毒药物组合物；一种用于预防或治疗由丙型肝炎病毒引起的肝病的药物组合物；以及一种制备该新型化合物的方法。